April 1, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By:

First Page		Document Content
Date: 2016-04-07 10:30:28 Business Pharmaceutical sciences Biotechnology Pharmacy Pharmaceutical industry Bristol-Myers Squibb Daiichi Sankyo Eli Lilly and Company Biopharmaceutical GlaxoSmithKline		April 1, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By: Add to Reading List Source URL: www.dcat.org Download Document from Source Website File Size: 324,19 KB Share Document on Facebook

	April 1, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. Sponsored By: DocID: 1rsbj - View Document
	benicar with hct what kind of med is benicar, benicar hc. benicar hct and insomnia. benicar hct tablets substitute benicar for micardis benicar contra drug side effect benicar benicar hct by daiichi-sankyo, benicar and b DocID: 1r6JO - View Document
	May 6, IMS Health, Quintiles Agree to Merge IMS Health Holdings, Inc., the pharmaceutical market information and technology provider, and Quintiles Transnational Holdings Inc., a contract rese DocID: 1p3Zj - View Document
	Press Release Daiichi Sankyo Provides Update on HER3-Lung Study of Patritumab in Non-Small Cell Lung Cancer (NSCLC) Tokyo, Japan and Parsippany, NJ– (May 31, 2016) – Daiichi Sankyo Company, Limited (hereafter, Daiich DocID: 1o6nw - View Document
	For Immediate Release ASAHIKAWA MEDICAL UNIVERSITY DAIICHI SANKYO COMPANY, LIMITED MITSUBISHI UFJ CAPITAL CO., LTD. Open innovation research on new stem cells by Asahikawa Medical University, DocID: 1o1QP - View Document